STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 17th, 2010 • Opko Health, Inc. • Surgical & medical instruments & apparatus
This Stock Purchase Agreement is entered into as of October 1, 2009, among the Laboratorio Volta S.A., a sociedad anónima cerrada organized and existing under the laws of Chile (“Volta”), Farmacias Ahumada S.A., a sociedad anónima abierta organized and existing under the laws of Chile (“FASA”), FASA Chile S.A., a sociedad anónima cerrada organized and existing under the laws of Chile (“FASA Chile” and collectively with Volta and FASA, the “Sellers”), OPKO Chile Limitada, a sociedad de responsabilidad limitada organized and existing under the laws of Chile, (“OPKO Chile), and Inversiones OPKO Limitada, a sociedad de responsabilidad limitada organized and existing under the laws of Chile, (“OPKO” and together with OPKO Chile, the “Buyers”) for the sale and transfer from the Sellers to the Buyers of 100% of Pharma Genexx S.A., a sociedad anónima cerrada organized and existing under the laws of Chile (the “Company”).
CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS ASSET PURCHASE AGREEMENT between SCHERING CORPORATION As SELLER and OPKO HEALTH, INC. As PURCHASER Dated as of October 12, 2009Asset Purchase Agreement • March 17th, 2010 • Opko Health, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of October 12, 2009 (the “Execution Date”) is entered into by and between Schering Corporation, a New Jersey corporation having a business address at 2000 Galloping Hill Road, Kenilworth, New Jersey 07033 (“Seller”); and OPKO Health, Inc., a Delaware corporation having a business address at 4400 Biscayne Boulevard, Miami, Florida 33137 (“Purchaser”). Seller and Purchaser are sometimes referred to, individually, as a “Party” and, collectively, as the “Parties.”
